Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prothena Corp Public (PRTA) Research & Development: 2011-2024

Historic Research & Development for Prothena Corp Public (PRTA) over the last 14 years, with Dec 2024 value amounting to $222.5 million.

  • Prothena Corp Public's Research & Development fell 42.95% to $28.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $170.4 million, marking a year-over-year decrease of 27.24%. This contributed to the annual value of $222.5 million for FY2024, which is 0.88% up from last year.
  • Prothena Corp Public's Research & Development amounted to $222.5 million in FY2024, which was up 0.88% from $220.6 million recorded in FY2023.
  • In the past 5 years, Prothena Corp Public's Research & Development ranged from a high of $222.5 million in FY2024 and a low of $74.9 million during FY2020.
  • Its 3-year average for Research & Development is $192.9 million, with a median of $220.6 million in 2023.
  • Data for Prothena Corp Public's Research & Development shows a peak YoY spiked of 64.75% (in 2022) over the last 5 years.
  • Prothena Corp Public's Research & Development (Yearly) stood at $74.9 million in 2020, then grew by 9.88% to $82.3 million in 2021, then spiked by 64.75% to $135.6 million in 2022, then soared by 62.71% to $220.6 million in 2023, then rose by 0.88% to $222.5 million in 2024.